- Home
- NAKA vs LNTH Comparison
NAKA vs LNTH Comparison
Compare NAKA & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAKA
- LNTH
- Stock Information
- Founded
- NAKA 2019
- LNTH 1956
- Country
- NAKA United States
- LNTH United States
- Employees
- NAKA N/A
- LNTH N/A
- Industry
- NAKA
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- NAKA
- LNTH Health Care
- Exchange
- NAKA Nasdaq
- LNTH Nasdaq
- Market Cap
- NAKA 3.8B
- LNTH 3.6B
- IPO Year
- NAKA 2024
- LNTH 2015
- Fundamental
- Price
- NAKA $1.13
- LNTH $53.83
- Analyst Decision
- NAKA Strong Buy
- LNTH Strong Buy
- Analyst Count
- NAKA 1
- LNTH 6
- Target Price
- NAKA $8.00
- LNTH $85.50
- AVG Volume (30 Days)
- NAKA 30.3M
- LNTH 1.5M
- Earning Date
- NAKA 11-11-2025
- LNTH 11-05-2025
- Dividend Yield
- NAKA N/A
- LNTH N/A
- EPS Growth
- NAKA N/A
- LNTH N/A
- EPS
- NAKA N/A
- LNTH 3.77
- Revenue
- NAKA $2,239,936.00
- LNTH $1,520,653,000.00
- Revenue This Year
- NAKA N/A
- LNTH N/A
- Revenue Next Year
- NAKA N/A
- LNTH $3.24
- P/E Ratio
- NAKA N/A
- LNTH $14.27
- Revenue Growth
- NAKA N/A
- LNTH 5.75
- 52 Week Low
- NAKA $0.65
- LNTH $47.25
- 52 Week High
- NAKA $34.77
- LNTH $118.21
- Technical
- Relative Strength Index (RSI)
- NAKA 34.34
- LNTH 50.57
- Support Level
- NAKA $1.06
- LNTH $49.75
- Resistance Level
- NAKA $1.19
- LNTH $54.43
- Average True Range (ATR)
- NAKA 0.15
- LNTH 1.51
- MACD
- NAKA 0.23
- LNTH 0.61
- Stochastic Oscillator
- NAKA 10.77
- LNTH 87.11
About NAKA Kindly MD Inc. Common Stock
Kindly MD Inc is a holistically focused pain management clinic and healthcare data company. It offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Its specialty outpatient clinical services are offered on a subscription and fee-for-service basis to augment traditional healthcare. The Company offers evaluation and management, including, but not limited to chronic pain, functional medicine, cognitive behavioral therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, travel services, and hormone therapy.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.